Ring 1
Ring 2
Ring 3
Ring 4


Financing Round

  • Series D+
Round Led by Symbiosis

Enterome is a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases. Enterome’s pioneering approach to drug discovery is based on its world-leading ability to decode the interaction between the gut microbiome and the immune system.

enterome View Website


  • Biologic


  • Gastroenterology
  • Immunology
  • Oncology

Development Status

  • Phase 2